$394.16
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Humana Inc. engages in the provision of health insurance services. The company is headquartered in Louisville, Kentucky and currently employs 67,060 full-time employees. The firm's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.
Country

US

CEO

Mr. James Rechtin

IPO date

1971

Employees

67,060

ISIN

US4448591028

Key stats

Open

$398.66

Volume

1.23M

Market cap

$47.76B

Prev. close

$397.76

Impl / hst vl

-

Open interest

$0.00

$391.31

Day’s Range

$398.66

$163.11

52W Range

$415.00

Valuation

27
Valuation score
Overvalued
P/E
42.36
P/S
0.35
P/B
2.58
Current ratio
-
Debt / Equity
0.49
ROE
6.19%
Gross margin
-
Income growth
-248.99%
FCF growth
-161.11

Jul

31

Dividends

The last payment date was Jul 31, 2026

Div. per Share

$0.89

Div. Yield

0.22%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Hold

The average rating from top 20 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$309.68
The top 28 analysts forecasts that 12-month price may decrease by 21.43%, with a low of $196.95 and a high of $463.05
$196.95
Low
$309.68
Avg
$463.05
High
Current price

Earnings

Q1 ‘26 revenue
$39.65B
Q1 ‘26 net income
$1.19B
Revenue
Net income
Previous EPS
$10.31
Estimate EPS
$7.27
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply